NEW YORK (TheStreet) -- Today on StockTwits, everyone is talking about mergers and acquisitions. It looks like a sign that the M&A market is heating up. Here are three potentially huge M&A deals that are breaking news this morning:
While the public seized on Mylan's price increases for EpiPens, the story of a common drug industry practice - increasing prices ahead of generics entering the market - got lost.
Pretty much every company you can think of has donated to the Clinton Foundation. So has Donald Trump. Should it matter?
Cramer says he doesn't understand the obsession some investors have with the Federal Reserve. Forget the Fed.
Jefferies increased its 2016 and 2017 earnings estimates for Pfizer (PFE) after the pharmaceutical company said it is purchasing Medivation (MDVN) for $14 billion.